| Tomková H, Kohoutek M, Zábojníková M, et al.
Cetuximab-induced cutaneous toxicity. [JOURNAL ARTICLE]
J Eur Acad Dermatol Venereol 2009 Nov 18.
Abstract | Full Citation | Find Related Articles |
| Lukan N, Ströbel P, Willer A, et al.
Cetuximab-Based Treatment of Metastatic Anal Cancer: Correlation of Response with KRAS Mutational Status. [JOURNAL ARTICLE]
Oncology 2009 Nov 17; 77(5):293-299.
Abstract | Full Citation |
| Mancl EE, Kolesar JM, Vermeulen LC
Clinical and economic value of screening for Kras mutations as predictors of response to epidermal growth factor receptor inhibitors. [JOURNAL ARTICLE]
Am J Health Syst Pharm 2009 Dec 1; 66(23):2105-2112.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Okamoto I
Epidermal growth factor receptor in relation to tumor development: EGFR-targeted anticancer therapy. [JOURNAL ARTICLE]
FEBS J 2009 Nov 18.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Pu XX, Deng YH, Xu F, et al.
[Effect of KRAS mutation on efficacy of Cetuximab combined with chemotherapy in advanced colorectal cancer patients.] [JOURNAL ARTICLE]
Zhonghua Wei Chang Wai Ke Za Zhi 2009 Nov; 12(6):594-597.
Abstract | Full Citation |
| Azzoli CG, Baker S, Temin S, et al.
American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer. [JOURNAL ARTICLE]
J Clin Oncol 2009 Nov 16.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Kies MS, Holsinger FC, Lee JJ, et al.
Induction Chemotherapy and Cetuximab for Locally Advanced Squamous Cell Carcinoma of the Head and Neck: Results From a Phase II Prospective Trial. [JOURNAL ARTICLE]
J Clin Oncol 2009 Nov 16.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| García-Sáenz JA, Sastre J, Díaz-Rubio García E
Biomarkers and anti-EGFR therapies for KRAS wild-type metastatic colorectal cancer. [Journal Article]
Clin Transl Oncol 2009 Nov; 11(11):737-47.
Abstract | Full Citation |
| Stinchcombe TE, Bradford DS, Hensing TA, et al.
A Multicenter Phase II Trial of Carboplatin and Cetuximab for Treatment of Advanced Nonsmall Cell Lung Cancer. [JOURNAL ARTICLE]
Cancer Invest 2009 Nov 16.
Abstract | Full Citation | Find Related Articles |
| Ciardiello F, Tejpar S, Papamichael D
Implications of KRAS mutation status for the treatment of metastatic colorectal cancer. [JOURNAL ARTICLE]
Target Oncol 2009 Nov 14.
Abstract | Full Citation |
  |
